The panel included retinoblastoma binding protein 9 (RBBP9), Caspase recruitment domain family 11 (CARD11), Fanconi anemia complementation group c (FANCC), double minute 4 (MDM4), and breast cancer 1 (BRCA1). Here, RBBP9 is linked to anemia.